Share Email Print
cover

Proceedings Paper

Transport, localization, and phototoxicity of m-THPC
Author(s): David Kessel; Elizabeth Sykes
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Since the photosensitizing agent mTHPC is insoluble in water, a formulation procedure, usually involving poly(ethylene glycol) and ethanol, is required for clinical and pre-clinical studies. Using this vehicle, we found that drug accumulation by murine leukemia L1210 cells in vitro was slow; only non-viable cells with damaged membranes showed rapid uptake of mTHPC. The drug ultimately localized in the cytosol, and subsequent irradiation led to mitochondrial > lysosomal >> membrane photodamage, and a rapid apoptotic response. The rate-limiting step in drug accumulation appears to involve dissociation of a transient albumin-bound aggregated species which exhibited a low fluorescence yield. Initial formation of this product may explain the unusual mTHPC pharmacokinetics in man recently reported. Dilution of mTHPC with human plasma led to a gradual increase in fluorescence yield as the drug became associated with lipoproteins and proteins. When a steady-state was reached, density-gradient ultracentrifugation indicated distribution of mTHPC to HDL > LDL >> albumin.

Paper Details

Date Published: 6 July 1999
PDF: 6 pages
Proc. SPIE 3592, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VIII, (6 July 1999); doi: 10.1117/12.351504
Show Author Affiliations
David Kessel, Wayne State Univ. School of Medicine (United States)
Elizabeth Sykes, William Beaumont Hospital (United States)


Published in SPIE Proceedings Vol. 3592:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VIII
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top